Removing Race Correction From Lung Function Test Changes Clinical Management
WEDNESDAY, Aug. 30, 2023 (HealthDay News) -- Removal of race correction from pulmonary function tests (PFTs) may change surgical management of lung cancer in African American patients, according to a study published Aug. 16 in JAMA Surgery.
Sidra N. Bonner, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues aimed to identify how many hospitals providing lung cancer surgery use race correction, examined the association of race correction with predicted lung function, and tested the effect of hypothetical vignettes on surgeons’ treatment recommendations for African American patients. The analysis included data from 515 African American patients who underwent lung cancer resection between Jan. 1, 2015, and Sept. 31, 2022.
The researchers found that 15 of 16 hospitals performing lung cancer resection for African American patients in Michigan reported using race correction, corresponding to 91.8 percent of African American patients having race-corrected PFTs. If race-neutral equations had been used, the percent predicted preoperative forced expiratory volume in 1 second (FEV1) and postoperative FEV1 would have decreased by 9.2 percent (P < 0.001) and 7.6 percent (P < 0.001), respectively. Among 225 cardiothoracic surgeons who completed treatment recommendations based on a randomized vignette, surgeons randomly assigned to the vignette with African American race-corrected PFTs were more likely to recommend lobectomy (79.2 percent) versus surgeons randomly assigned to the other race or multiracial-corrected vignette (61.7 percent; P = 0.02) or race-neutral PFTs (52.8 percent; P = 0.001).
“It is important that race-correction in spirometry tests is removed given that it is based on the flawed concept of race as a biological factor,” Bonner said in a statement. “For African Americans with lung cancer being evaluated for surgery, this may exacerbate existing disparities in lung cancer care.”
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Prevalence of Adrenal Tumors Studied in Adults in China
TUESDAY, Sept. 13, 2022 (HealthDay News) -- The prevalence of adrenal tumors is...
AHA News: Get Past Its Spines and Reap Health Benefits From the Prickly Pear Cactus
FRIDAY, Aug. 4, 2023 (American Heart Association News) -- Covered in menacing...
SGLT2i Use Linked to Reduced Risk for Flare in Adults With Gout, T2D
MONDAY, July 24, 2023 (HealthDay News) -- For patients with gout and type 2...
Chest CT Prior to Stem Cell Transplant Beneficial for Spotting Abnormalities
FRIDAY, Feb. 24, 2023 (HealthDay News) -- Pretransplant screening chest computed...